NCT06737367View on ClinicalTrials.gov

Integrating Machine Learning for Prognostic Prediction in Stage I NSCLC by CT Images and Pathological Factors

CompletedOBSERVATIONAL

Enrollment

800

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

September 20, 2024

Study Completion Date

November 11, 2024

Conditions

Lung Cancer - Non Small Cell

Interventions

OTHER

CT radiomic analysis

Radiomic features of tumor and peritumor tissue

Trial Locations (1)

Unknown

Jinling Hospital, China, Nanjing

All Listed Sponsors

lead

Jinling Hospital, China

OTHER

NCT06737367 - Integrating Machine Learning for Prognostic Prediction in Stage I NSCLC by CT Images and Pathological Factors | Biotech Hunter | Biotech Hunter